Requisite models for strategic commissioning: the example of type 1 diabetes

Mara Airoldi, Gwyn Bevan, Alec Morton, Mónica Oliveira, Jenifer Smith

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

A developing emphasis of health care reforms has been creating organisations with responsibilities for strategic commissioning of services for defined populations. Such organisations must set priorities in aiming to meet their populations’ needs subject to a budget constraint. This requires estimates of the health benefits and costs of different interventions for their populations. This paper outlines a framework that does this and shows how this requires modelling to produce estimates in a way that is transparent to commissioners, of requisite complexity to produce sound estimates for priority setting using routinely available data. The example illustrated in this paper is an intervention that would improve glucose control in the English population with type 1 diabetes. It takes many years for a change in glucose management to deliver maximum benefits; hence the intervention is not good value-for-money in the short run. We aim to give a more strategic view of the costs and benefits modelling costs and benefits in a steady-state model which suggests that the intervention is good value-for-money in the long run
LanguageEnglish
Pages89-110
Number of pages22
JournalHealth Care Management Science
Volume11
Issue number2
DOIs
Publication statusPublished - 1 Jun 2008

Fingerprint

Type 1 Diabetes Mellitus
Cost-Benefit Analysis
Population
Organizations
Glucose
Health Care Reform
Insurance Benefits
Budgets
Health Care Costs
Diabetes
Modeling
Value for money
Costs and benefits

Keywords

  • requisite models
  • strategic commissioning
  • type 1 diabetes
  • operations research/decision theory
  • business/management science
  • general econometrics
  • management
  • health informatics
  • health administration

Cite this

Airoldi, Mara ; Bevan, Gwyn ; Morton, Alec ; Oliveira, Mónica ; Smith, Jenifer. / Requisite models for strategic commissioning : the example of type 1 diabetes. In: Health Care Management Science. 2008 ; Vol. 11, No. 2. pp. 89-110.
@article{72d7db56f15b476aa77e7ac49ff2e5c2,
title = "Requisite models for strategic commissioning: the example of type 1 diabetes",
abstract = "A developing emphasis of health care reforms has been creating organisations with responsibilities for strategic commissioning of services for defined populations. Such organisations must set priorities in aiming to meet their populations’ needs subject to a budget constraint. This requires estimates of the health benefits and costs of different interventions for their populations. This paper outlines a framework that does this and shows how this requires modelling to produce estimates in a way that is transparent to commissioners, of requisite complexity to produce sound estimates for priority setting using routinely available data. The example illustrated in this paper is an intervention that would improve glucose control in the English population with type 1 diabetes. It takes many years for a change in glucose management to deliver maximum benefits; hence the intervention is not good value-for-money in the short run. We aim to give a more strategic view of the costs and benefits modelling costs and benefits in a steady-state model which suggests that the intervention is good value-for-money in the long run",
keywords = "requisite models, strategic commissioning, type 1 diabetes, operations research/decision theory, business/management science, general econometrics, management, health informatics, health administration",
author = "Mara Airoldi and Gwyn Bevan and Alec Morton and M{\'o}nica Oliveira and Jenifer Smith",
year = "2008",
month = "6",
day = "1",
doi = "10.1007/s10729-008-9056-9",
language = "English",
volume = "11",
pages = "89--110",
journal = "Health Care Management Science",
issn = "1386-9620",
number = "2",

}

Requisite models for strategic commissioning : the example of type 1 diabetes. / Airoldi, Mara; Bevan, Gwyn; Morton, Alec; Oliveira, Mónica ; Smith, Jenifer.

In: Health Care Management Science, Vol. 11, No. 2, 01.06.2008, p. 89-110.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Requisite models for strategic commissioning

T2 - Health Care Management Science

AU - Airoldi, Mara

AU - Bevan, Gwyn

AU - Morton, Alec

AU - Oliveira, Mónica

AU - Smith, Jenifer

PY - 2008/6/1

Y1 - 2008/6/1

N2 - A developing emphasis of health care reforms has been creating organisations with responsibilities for strategic commissioning of services for defined populations. Such organisations must set priorities in aiming to meet their populations’ needs subject to a budget constraint. This requires estimates of the health benefits and costs of different interventions for their populations. This paper outlines a framework that does this and shows how this requires modelling to produce estimates in a way that is transparent to commissioners, of requisite complexity to produce sound estimates for priority setting using routinely available data. The example illustrated in this paper is an intervention that would improve glucose control in the English population with type 1 diabetes. It takes many years for a change in glucose management to deliver maximum benefits; hence the intervention is not good value-for-money in the short run. We aim to give a more strategic view of the costs and benefits modelling costs and benefits in a steady-state model which suggests that the intervention is good value-for-money in the long run

AB - A developing emphasis of health care reforms has been creating organisations with responsibilities for strategic commissioning of services for defined populations. Such organisations must set priorities in aiming to meet their populations’ needs subject to a budget constraint. This requires estimates of the health benefits and costs of different interventions for their populations. This paper outlines a framework that does this and shows how this requires modelling to produce estimates in a way that is transparent to commissioners, of requisite complexity to produce sound estimates for priority setting using routinely available data. The example illustrated in this paper is an intervention that would improve glucose control in the English population with type 1 diabetes. It takes many years for a change in glucose management to deliver maximum benefits; hence the intervention is not good value-for-money in the short run. We aim to give a more strategic view of the costs and benefits modelling costs and benefits in a steady-state model which suggests that the intervention is good value-for-money in the long run

KW - requisite models

KW - strategic commissioning

KW - type 1 diabetes

KW - operations research/decision theory

KW - business/management science

KW - general econometrics

KW - management

KW - health informatics

KW - health administration

U2 - 10.1007/s10729-008-9056-9

DO - 10.1007/s10729-008-9056-9

M3 - Article

VL - 11

SP - 89

EP - 110

JO - Health Care Management Science

JF - Health Care Management Science

SN - 1386-9620

IS - 2

ER -